Cardiac Magnetic Resonance in Pulmonary Hypertension—an Update

Samer Alabed, Pankaj Garg, Christopher S. Johns, Faisal Alandejani, Yousef Shahin, Krit Dwivedi, Hamza Zafar, James M Wild, David G Kiely, Andrew J Swift

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Purpose of Review

This article reviews advances over the past 3 years in cardiac magnetic resonance (CMR) imaging in pulmonary hypertension (PH). We aim to bring the reader up-to-date with CMR applications in diagnosis, prognosis, 4D flow, strain analysis, T1 mapping, machine learning and ongoing research.

Recent Findings

CMR volumetric and functional metrics are now established as valuable prognostic markers in PH. This imaging modality is increasingly used to assess treatment response and improves risk stratification when incorporated into PH risk scores. Emerging techniques such as myocardial T1 mapping may play a role in the follow-up of selected patients. Myocardial strain may be used as an early marker for right and left ventricular dysfunction and a predictor for mortality. Machine learning has offered a glimpse into future possibilities. Ongoing research of new PH therapies is increasingly using CMR as a clinical endpoint.

Summary

The last 3 years have seen several large studies establishing CMR as a valuable diagnostic and prognostic tool in patients with PH, with CMR increasingly considered as an endpoint in clinical trials of PH therapies. Machine learning approaches to improve automation and accuracy of CMR metrics and identify imaging features of PH is an area of active research interest with promising clinical utility.
Original languageEnglish
Article number30
JournalCurrent Cardiovascular Imaging Reports
Volume13
Issue number12
DOIs
Publication statusPublished - 7 Nov 2020

Keywords

  • CMR
  • Cardiac MRI
  • Pulmonary hypertension

Cite this